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In 1883, Ringer alerted the biological world to the fact that calcium played an 
important role in muscle contraction.’ In 191 1, Cow described the extensive studies 
that he had carried out on isolated vascular smooth muscle.’ H e  recorded the responses 
of this muscle to many pharmacological and physiological agents and studied the 
influence of calcium on these responses. 
In the current review I will try to sum up what we have learned about the actions of 
calcium on smooth muscle since this early beginning. These actions of calcium will be 
reviewed from three aspects: (1) how calcium activates the contractile protein, (2) how 
the concentration of activator calcium is regulated, and (3) how calcium affects the 
plasma membrane. 
CALCIUM AND THE CONTRACTILE PROTEINS 
The central consideration given to the role played by calcium in muscle contraction 
is its activation of the chemomechanical transducing system that converts energy from 
the physiological fuel, ATP, to developed force. Calcium is the “spark plug” that puts 
the contractile proteins “in motion.” 
It is now well established that the role played by this activator calcium as the spark 
plug for contraction of vertebrate skeletal muscle is indirect. Ebashi et al. observed 
that when they combined purified actin (from which the troponin-tropomyosin system 
had been removed) with myosin, calcium was not necessary for super precipitation of 
the resultant, purified ac tomy~sin .~  In the intact, resting muscle and in extracted, 
native actomyosin, the ATPase activity of actomyosin is inhibited by a complex 
cooperative influence of troponin and tropomyosin. This inhibitory action of the 
troponin-tropomyosin system is eliminated when calcium combines with one of the 
troponins, TN-C. The binding of calcium to TN-C has the same calcium concentration 
dependence as does the activation of native actomyosin ATPase. The action of calcium 
is not a direct activation, but instead it is a disinhibition of the troponin-tropomyosin 
system. Because in the native state these inhibitory proteins are bound to actin in the 
thin filaments, this regulatory system is referred to as the actin or thin-filament 
regulatory system. 
In 1965, we demonstrated that the calcium requirement for contraction of smooth 
muscle of the pig carotid artery was identical to that of the skeletal muscle of the rabbit 
psoas! From these observations we concluded that the molecular mechanism by which 
calcium regulated the contraction of vascular smooth muscle was the same as that 
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which Ebashi has characterized for striated muscle. Because of this conclusion, we 
credit ourselves with having delayed by a decade the correct understanding of the 
mechanism by which calcium activates the contractile process of smooth muscle. 
It is now known that the calcium regulatory system of vertebrate smooth muscle is 
myosin linked as it is in molluscan muscle.’ Bremel et al. observed that purified myosin 
from vertebrate smooth muscle could not be activated by pure actin from vertebrate 
skeletal muscle in the absence of calcium.6 Calcium activated this hybrid actomyosin 
which had no TN-C. 
In the smooth muscle cell, calcium activates a kinase that causes the phosphoryla- 
tion of myosin light chain. Once phosphorylated, the actomyosin becomes an active 
ATPase and the myosin bridges cycle to generate active force.’ The sensitivity of the 
activation of the myosin light chain kinase by calcium is increased tenfold by 
calmodulin.* In a recent study using aequorin to monitor intracellular calcium 
concentration in swine carotid media, Rembold and Murphy demonstrated convinc- 
ingly the correlations between intracellular calcium concentration, myosin light chain 
phosphorylation, and cross bridge cycling rate? They also observed that although these 
three variables were transient following stimulation of the muscle, the developed stress 
persisted in what they have called the “latch state.” Based on these and other 
observations Hai and Murphy have described a kinetic model that hypothesized two 
types of cross bridge interactions: ( 1 )  cycling phosphorylated cross bridges and (2) 
noncycling dephosphorylated cross bridges (“latch bridges”) .lo The only calcium- 
dependent regulatory mechanism in this model is myosin light chain kinase activation. 
They conclude that myosin phosphorylation is both necessary and sufficient for the 
development of the latch state. 
REGULATION AND ACTIVATOR CALCIUM 
These investigations have provided a comfortable understanding of the mechanism 
of contraction of vascular smooth muscle and have made it clear that this contraction is 
regulated by the concentration of calcium in the myoplasm. Parallel research has 
developed insight into the processes that regulate this calcium concentration. Broadly 
considered, these processes are involved either in the movement of calcium across the 
plasma membrane or in the sequestration and release of calcium from the sarcoplasmic 
reticulum. 
In 1963 we found it possible to differentiate contractile responses to calcium from 
these two sources” when we observed that the response of the rabbit aorta was 
comprised of a fast and a slow component. We and othersI2 established that calcium for 
the fast component had its origin from intracellular sequestered sites whereas that for 
the slow component had its origin from the extracellular calcium pool. 
Calcium for the fast component of the contraction is released from the sarcoplas- 
mic reticulum when a constrictor agonist activates its specific receptors in the plasma 
membrane. Somlyo and Somlyo have named this process pharmacomechanical 
co~pling.’~ It can occur without a change in membrane potential. The role of an 
intracellular source of calcium in response to physiological agonist is demonstrated by 
the observation that vascular smooth muscle contracts phasically when stimulated with 
norepinephrine (NE) in a calcium-free medium.12 Further evidence of this intracellu- 
lar release of sequestered calcium in response to a receptor-agonist complex is found in 
the observation that 45Ca efflux increases when 4’Ca-loaded vascular smooth muscle is 
stimulated with NE.14 The signal for calcium release is transmitted to the sacroplasmic 
reticulum either by calcium-induced calcium release” or by inositol trisphosphate.‘6 
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In the absence of these signals the sarcoplasmic reticulum activity sequesters 
calcium, and it has been established that in vascular smooth muscle these microsomes 
hold sufficient calcium “to be both sink and source for the activator calcium in 
excitation-contraction coupling.”” Van Breemen et al. have called our attention to the 
important role that the sarcoplasmic reticulum must play in buffering increments in 
intracellular calcium concentration.’* They have presented evidence that N E  blocks 
this buffering action and thereby causes a further increase in intracellular calcium 
concentration. 
Extensive insight has also been developed into the roles played by the plasma 
membrane in the regulation of intracellular calcium concentration. Fundamental to 
this regulation is the fact that extracellular calcium concentration is approximately 
10,000 times greater than that inside of the resting smooth muscle cell. For this reason 
the regulatory role of the plasma membrane is largely dependent on its permeability to 
calcium. This permeability is governed by the status of specific protein channels in the 
lipid bilayer of the membrane. Some channels open when the membrane is depolarized 
(potential-sensitive channels); others open when agonists react with their membrane 
receptors (receptor-operated channels).” Extensive evidence has established that these 
two classes of channels are different. For instance, they respond differently to calcium 
entry blockers” and to calcium agonists.” 
The role of the membrane in regulating intracellular calcium concentration is 
influenced by the concentrations of potassium and sodium in its environment. 
Indirectly this influence reflects the roles that these monovalent cations have as 
determinants of membrane potential and hence on the opening of the potential- 
sensitive calcium channel. The concentration of these ions regulates membrane 
potential directly by their diffusion potentials and indirectly by their regulation of the 
activity of the electrogenic sodium pump. An increase in the activity of this pump 
causes membrane hyperpolarization, hence closure of the potential-sensitive channels 
and vascular smooth muscle relaxation.” 
There is now being considered a more direct role for the sodium ion in regulating 
the transmembrane calcium movement in vascular smooth muscle. A specific sodium- 
calcium exchange mechanism was first critically characterized in the squid axon.” 
With the normal high transmembrane concentration gradient of sodium, the flow of 
this ion down its concentration gradient into the cell through this exchange system 
energizes the extrusion of calcium from the cell. When the sodium concentration 
gradient is reduced either by decreasing extracellular sodium or by increasing 
intracellular sodium, calcium concentration inside the cell increases. Briggs and 
Melvin observed that when rabbit aortic strips were exposed to a low sodium 
concentration, calcium influx increased by 225% and contracture developed.” Several 
investigators have attributed the contracture that develops when the sodium pump of 
vascular smooth muscle is inhibited, to the increase in intracellular sodium that 
dissipates the sodium gradient that is normally responsible for calcium extrusion via 
this sodium-calcium exchange Although extensive arguments have been 
advanced supporting the physiological significance of this exchange system,27 its 
importance is not universally accepted.” 
Another substantive membrane system involved in the regulation of intracellular 
calcium concentration is the energy-requiring calcium-extrusion pump. When the 
smooth muscle cell is metabolically inhibited calcium accumulates intracellularly a t  
the rate of its leak into the resting cell, demonstrating the essential homeostatic role of 
the calcium-extrusion The functional significance of this pump is suggested by 
the vasodilation by nitroglycerine that stimulates the pump:’ and the vascular smooth 
muscle contraction that results from its inhibition with  ana ad ate.^' 
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CALCIUM AND THE PLASMA MEMBRANE 
Not only is the plasma membrane equipped with many mechanisms that are 
important regulators of intracellular calcium concentration, but the function of the 
membrane is itself regulated by calcium. Intracellular functions are protected from 
excessive calcium concentration, since an increase in extracellular calcium concentra- 
tion causes a decrease in cell membrane permeability to calcium. Increases in 
extracellular calcium concentration cause a decrease in 45Ca influx in vascular smooth 
muscle.32p33 This inactivation of calcium channels by increasing concentations of 
calcium can be demonstrated by the relaxation of vascular smooth muscle that occurs 
when extracellular calcium concentration is increased above physiological levels.34 
Increases in calcium concentration also cause a cessation of action potentials in the 
taenia c ~ l i . ~ ’  The decrease in membrane permeability caused by the increase in 
calcium concentration is referred to as membrane stabilization. It is a generalized 
effect, as evidenced by the observations that it results in a decrease in potassium flux 
through the vascular smooth muscle membrane36 and it produces identical permeabil- 
ity changes in the membrane of the lymph~cyte .~’  The converse is also true in that a 
decrease in extracellular calcium concentration results in an increase in membrane 
excitability. Clinically this is recognized in hypocalcemic tetany, and we have observed 
that it causes an increase in membrane excitability in vascular smooth muscle.“ 
More recently we have used an alternate technique to evaluate the influence of 
membrane-bound calcium on its ~ e r m e a b i l i t y . ~ ~  In this technique the vascular smooth 
muscle is placed in a calcium-free solution for 5 minutes with the sodium pump shut 
down by a potassium-free solution. Calcium is then added back to the muscle bath 
causing a contraction, the time course of which is determined by the rate of calcium 
entry into the cell through the plasma membrane which, in turn, is regulated by the 
amount of calcium that had remained bound to the membrane during the 5 minutes 
exposure to the calcium-free solution. This regulatory role of calcium bound to the 
membrane is demonstrated by exposing the muscle to 1 m M  EGTA in a calcium-free 
solution for 1 minute before the 5 minute period in a calcium-free solution without 
EGTA. The 1 minute exposure to EGTA removes calcium from the membrane. Now 
when the calcium is added back 5 minutes later it enters the cell easily giving rise to a 
much faster contractile response. Using this technique we have confirmed results of 
other s t ~ d i e s ~ ~ , ~ ~  indicating that in experimental hypertension there is a deficiency of 
membrane binding sites on which calcium has this stabilizing action. 
As characterized by Johnson et al. all aspects of the relationships of calcium to 
vascular smooth muscle functions are mediated through calcium-binding proteins.26 
The future of this field will depend on a further understanding of the role played by 
these proteins. 
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